If these trials confirm the findings, benralizumab could become the first new therapy approved for eosinophilic exacerbations ...

"But it's appalling that this is the first new treatment for those suffering from asthma and COPD attacks in 50 years, indicating how desperately underfunded lung health research is. "Every four ...

Verona Pharma is off to a promising start as it launches its first product, Ohtuvayre, a maintenance treatment for chronic obstructive pulmonary disorder (COPD). In 2024, Ohtuvayre generated sales ...

Chronic obstructive pulmonary disease (COPD) is a manifestation of structural violence, the process through which societies ...

The expectations of the treatment should also ... patient is heading towards. In the new GOLD guidelines, only administering the influenza vaccine to all COPD patients was added to the guidelines.

inhalers can help relieve your COPD symptoms. Ask your doctor to show you how to use your specific inhaler. Be sure to keep track of the expiration dates on your medication and get a new ...

New handheld models are about the size ... nebulizers are available that you can use to help treat your COPD. Each converts the medication you take into a mist that you breathe in.

Researchers have identified new lung function and blood test cutoffs to improve timely chronic hypercapnia management in ...

These researchers found that the new classification thresholds affect ... Early evidence suggests promise for a novel COPD treatment using autologous P63+ lung progenitor cell.

People with COPD experience more falls and related injuries requiring medical care when using common fall-risk increasing ...

There is an increasing interest in the frequency of COPD exacerbations, since this was found to relate to prevention and treatment. Most of the new drugs being investigated and developed are ...

McDermott et al, Fall Risk and Medication Use Near End of Life Among Adults With Chronic Obstructive Pulmonary Disease, Chronic Obstructive Pulmonary Diseases: Journal of the COPD Foundation (2024).